As of January 2026 Regentis Biomaterials has a market cap of NZ$56.92 Million. This makes Regentis Biomaterials the world's 10003th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 12th, 2026 the market cap of Regentis Biomaterials was reported to be: